Company Filing History:
Years Active: 2018
Title: Antonio Germani: Innovator in Immunomodulatory Drug Development
Introduction
Antonio Germani is a notable inventor based in Lugano, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel solid crystal forms of immunomodulatory drugs. His work is crucial for advancing treatments for various diseases.
Latest Patents
Germani holds a patent for "Crystal forms of immunomodulatory drug pomalidomide and co-crystal with gentisic acid." This invention relates to novel solid crystal forms of Pomalidomide, specifically Form B, Form M, and the Pomalidomide:Gentisic acid co-crystal. These solid forms are advantageous in pharmaceutical compositions for treating and preventing multiple myeloma, inflammatory diseases, autoimmune diseases, immune diseases, myelodysplastic syndrome, myeloproliferative disorders, anemia, scleroderma, amyloidosis, and other diseases associated with unwanted angiogenesis. He has 1 patent to his name.
Career Highlights
Germani is associated with F.i.s. Fabbrica Italiana Sintetici S.p.a., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in enhancing the efficacy of treatments for serious health conditions.
Collaborations
He collaborates with notable colleagues, including Alessandro Gagnoni and Nicolas Tesson, contributing to a dynamic research environment that fosters innovation.
Conclusion
Antonio Germani's contributions to the field of immunomodulatory drugs exemplify the impact of innovative thinking in pharmaceuticals. His work not only advances medical science but also offers hope for patients suffering from various diseases.